HÆMODIALYSIS IN ACUTE PORPHYRIA

1963 ◽  
Vol 2 (18) ◽  
pp. 749-750 ◽  
Author(s):  
P. M. Last
Keyword(s):  
2020 ◽  
Vol 135 ◽  
pp. 80S ◽  
Author(s):  
Tomi T. Kanninen ◽  
Emily Stroobant ◽  
Rebecca Pierce-Williams ◽  
Seth Berger ◽  
Huda B. Al-Kouatly

2013 ◽  
Vol 85 (3) ◽  
pp. 1207-1214 ◽  
Author(s):  
ANNA R.R. DOS SANTOS ◽  
RAFAELA R. DE ALBUQUERQUE ◽  
MARIA J.R. DORIQUI ◽  
GRACIOMAR C. COSTA ◽  
ANA PAULA S.A. DOS SANTOS

Acute intermittent porphyria is the most common acute porphyria caused by a decrease in hepatic porphobilinogen deaminase activity, resulting in an accumulation of delta-aminolevulinic acid and porphobilinogen. This disease shows nonspecific signs and symptoms that can be confused with other diseases, thereby making the diagnosis difficult. We report a case of acute intermittent porphyria, reviewing clinical and laboratory aspects, highlighting the hematological and biochemical parameters during and after the crisis. A female patient, aged 28 years, suffered two crises, both presenting gastrointestinal disorders. The second presented neuropsychiatric symptoms. The analysis of hematological and biochemical parameters during the second crisis showed anemia, leukocytosis, hyponatremia, mild hypokalemia, uremia and elevated C-reactive protein. The initial treatment included glucose infusion, a diet rich in carbohydrates and interruption of porphyrinogenic drugs. Subsequently, treatment was maintained with oral contraceptive use. According to the observed data, signs and symptoms of gastrointestinal, neurological and psychiatric disorders, associated with laboratory results presented in this paper can be applied to screen acute porphyria, contributing to early diagnosis.


AIDS ◽  
2015 ◽  
Vol 29 (8) ◽  
pp. 981-982 ◽  
Author(s):  
Christopher W. Pavitt ◽  
Tommy Rampling ◽  
Ruth Byrne ◽  
Sara Tyebally ◽  
Tom Reid ◽  
...  
Keyword(s):  

1946 ◽  
Vol 77 (6) ◽  
pp. 623 ◽  
Author(s):  
F. T. G. PRUNTY
Keyword(s):  

Author(s):  
Lianne Abrahams

Pandemic Covid-19 pneumonia, of SARS-CoV-2 aetiology, is of global importance to health systems, national economies, and individual civil liberties. Multiple therapeutic and prophylactic agents are currently undergoing clinical trial and, while progress towards a curative agent is promising, the principal limiting factor in public health emergency is time. A pre-existing licensed therapeutic would offer reprieve to international citizens currently enduring the adverse consequences of lockdown policies. The current review advances the author’s original hypothesis and advocates direct testing of the hypothesis by urinalysis of light-protected samples from critical Covid-19 patients to check for elevated aminolevulinic acid and porphobilinogen.


The Lancet ◽  
1983 ◽  
Vol 321 (8328) ◽  
pp. 790-792 ◽  
Author(s):  
AlbertA.C Yeung Laiwah ◽  
GeorgeG Thompson ◽  
MaryF Philip ◽  
MartinJ Brodie ◽  
W Garth Rapeport ◽  
...  
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document